4723-9-10 Formulary.

 

 

 

4723-9-10                    Formulary.

 

 

 

(A)   The formulary, as established by the committee on prescriptive governance, shall be available on the Ohio board of nursing web site.

 

(B)  The committee on prescriptive governance shall review the formulary for additions or deletions at least once a year.

 

(C)    The  committee  on  prescriptive  governance  shall  establish  a  formulary  and  may exclude subtypes or individual drugs within the following types of drugs:

 

(1)   Nutrients and nutritional agents;

 

(2)   Hematological agents;

 

(3)   Endocrine and metabolic agents;

 

(4)   Cardiovascular agents;

 

(5)   Renal and genitourinary agents;

 

(6)   Respiratory agents;

 

(7)   Central nervous system agents;

 

(8)   Gastrointestinal agents;

 

(9)   Anti-infective and systemic agents;

 

(10)   Biologic/immunologic agents;

 

(11)   Dermatologic agents;

 

(12)   Opthalmic and otic agents;

 

(13)   Antineoplastic agents; and

 

(14)   Diagnostic aids.

 

(D)    A nurse with a current valid certificate to prescribe may prescribe a schedule II

 

 

 

controlled substance only in situations where all of the following apply:

(1)   A patient has a terminal condition;

(2)    The nurse's collaborating physician initially prescribed the substance for the patient; and

(3)   The prescription is for a quantity that does not exceed the amount necessary for the patient's use in a single, twenty-four hour period.

(E)    A nurse holding a current valid certificate to prescribe may prescribe any drug or therapeutic device in any form and route of administration which is included on the formulary and as agreed to by the collaborating physician in the standard care arrangement. The ability to prescribe the drug or therapeutic device must be within the nurse's scope of practice.

(F)   Drugs approved by the FDA subsequent to the date of the adoption of these rules shall not be prescribed until reviewed and approved by the committee on prescriptive governance.

(G)  For purposes of interpreting the formulary, the following definitions shall apply:

(1)    "Physician consultation" means a nurse holding a current, valid certificate to prescribe may initiate the medication after direct communication with the collaborating physician regarding a particular patient and documenting the consultation in the patient record. Once the medication is initially authorized by the collaborating physician, a nurse holding a current valid certificate to prescribe may continue, modify, or discontinue the medication without further consultation.

(2)   "Physician initiation" means the collaborating physician is required to write the initial order for the medicationhave personally examined and evaluated the patient before therapy is initiated in accordance with rule 4731-11-09 of the Administrative Code. This includes the requirement thatFollowing discussion with the collaborating physician, the initial order or prescription may be written by an advanced practice nurse holding a current valid certificate to prescribe personally physically examine and diagnose the patient prior to prescribing. Once the drug is initially ordered by the collaborating physician, a nurse holding a current, valid certificate to prescribe therapy has been initiated, the advanced practice nurse may continue, modify, or discontinue the medication without further consultation.

Effective:                                                     02/01/2008

R.C. 119.032 review dates:                         10/01/2010

CERTIFIED ELECTRONICALLY

Certification

12/21/2007

Date

Promulgated Under:                           119.03

Statutory Authority:                           RC 4723.50

Rule Amplifies:                                  RC 4723.49, 4723.491, 4723.492

Prior Effective Dates:                         2/1/02, 2/1/03, 2/1/06